References
- Seckl MJ , SebireNJ, BerkowitzRS. Gestational trophoblastic disease. Lancet376(9742), 717–729 (2010).
- Abu-Rustum NR , YasharCM, BeanSet al. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J. Natl Compr. Canc. Netw.17(11), 1374–1391 (2019).
- Wang Q , FuJ, HuLet al. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia. Cochrane Database Systemat. Rev. doi:10.1002/14651858.CD007289.pub3(9), (2017).
- Jiang F , LinJK, XiangYet al. The impact of pulmonary metastases on therapeutic response and prognosis in malignant gestational trophoblastic neoplasia patients: a retrospective cohort study. Eur. J. Cancer161, 119–127 (2022).
- Pradjatmo H , DasukiD, DwianingsihEK, TriningsihE. Malignancy risk scoring of hydatidiform moles. Asian Pac. J. Cancer Prev.16(6), 2441–2445 (2015).
- Ngan HYS , SecklMJ, BerkowitzRSet al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int. J. Gynaecol. Obstet.155(Suppl. 1), 86–93 (2021).
- Qin J , ZhangS, PoonLet al. Doppler-based predictive model for methotrexate resistance in low-risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients. Ultrasound Obstet. Gynecol.57(5), 829–839 (2021).
- Shih Ie M . Gestational trophoblastic neoplasia – pathogenesis and potential therapeutic targets. Lancet Oncol.8(7), 642–650 (2007).
- Veras E , KurmanRJ, WangTL, ShihIM. PD-L1 expression in human placentas and gestational trophoblastic diseases. Int. J. Gynecol. Pathol.36(2), 146–153 (2017).
- Templeton AJ , McnamaraMG, ŠerugaBet al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl Cancer Inst.106(6), dju124 (2014).
- Ethier JL , DesautelsD, TempletonA, ShahPS, AmirE. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res.19(1), 2 (2017).
- Li YX , ChangJY, HeMYet al. Neutrophil-to-lymphocyte ratio (NLR) and monocyte-to-lymphocyte ratio (MLR) Predict clinical outcome in patients with stage IIB cervical cancer. J. Oncol.2021, 2939162 (2021).
- Hirahara T , ArigamiT, YanagitaSet al. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer. BMC Cancer19(1), 672 (2019).
- Leng J , WuF, ZhangL. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, or monocyte-to-lymphocyte ratio in endometrial neoplasms: a systematic review and meta-analysis. Front. Oncol.12, 734948 (2022).
- Guzel AI , KokanaliMK, ErkilincSet al. Predictive role of the neutrophil lymphocyte ratio for invasion with gestational trophoblastic disease. Asian Pac. J. Cancer Prev.15(10), 4203–4206 (2014).
- Chen Y , ZhangH. Predictive role of the neutrophil-lymphocyte ratio for hydatidiform mole canceration. J. Pract. Obstet. Gynecol.32(04), 294–297 (2016).
- Abide Yayla C , ÖzkayaE, YenidedeIet al. Predictive value of some hematological parameters for non-invasive and invasive mole pregnancies. J. Matern.-Fetal Neonat. Med.31(3), 271–277 (2017).
- Zhang S , ShaoJ, ZhangL. Predictive value of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, hunman chronic gonadotropin and maximum diameter of intrauterine mass for prognosis of hydatidiform moles. Guangxi Med. J.41(22), 2875–2878 (2019).
- Liu R , ZhangT, HuJ, AnR. Predictive value of peripheral systemic inflammatory markers in the malignancy transformation of complete hydatidiform mole. J. Pract. Obstet. Gynecol.36(01), 31–36 (2020).
- Zhang X , TanR, LamWCet al. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020). Am. J. Chin. Med.48(6), 1279–1313 (2020).
- Jiang F , WanXR, XuTet al. Evaluation and suggestions for improving the FIGO 2000 staging criteria for gestational trophoblastic neoplasia: a ten-year review of 1420 patients. Gynecol. Oncol.149(3), 539–544 (2018).
- Benedet JL , BenderH, JonesH3rd, NganHY, PecorelliS. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int. J. Gynaecol. Obstet.70(2), 209–262 (2000).
- Zheng WF , ZhanJ, ChenA, MaH, YangH, MaharjanR. Diagnostic value of neutrophil-lymphocyte ratio in preeclampsia: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore)98(51), e18496 (2019).
- Whiting PF , RutjesAW, WestwoodMEet al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med.155(8), 529–536 (2011).
- Catenacci V , SheikhF, PatelK, Fox-RobichaudA. Diagnostic and prognostic accuracy of Protein C in adult patients with sepsis: protocol for a systematic review and meta-analysis. BMJ Open11(9), e050754 (2021).
- Higgins JP , ThompsonSG, DeeksJJ, AltmanDG. Measuring inconsistency in meta-analyses. BMJ327(7414), 557–560 (2003).
- Abi Nahed R , ReynaudD, BorgAJet al. NLRP7 is increased in human idiopathic fetal growth restriction and plays a critical role in trophoblast differentiation. J. Mol. Med.97(3), 355–367 (2019).
- Soellner L , BegemannM, DegenhardtF, GeipelA, EggermannT, MangoldE. Maternal heterozygous NLRP7 variant results in recurrent reproductive failure and imprinting disturbances in the offspring. Eur. J. Hum. Genet.25(8), 924–929 (2017).
- Tsai P-Y , ChenK-R, LiY-C, KuoP-L. NLRP7 Is involved in the differentiation of the decidual macrophages. Int. J. Mol. Sci.20(23), 5994 (2019).
- Tas M , YavuzA, AkM, OzcelikB. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in discriminating precancerous pathologies from cervical cancer. J. Oncol.2019, 2476082 (2019).
- Zhang L , XieY, ZhanL. The potential value of red blood cell distribution width in patients with invasive hydatidiform mole. J. Clin.Lab. Anal.33(4), e22846 (2019).
- Ngan HYS , SecklMJ, BerkowitzRSet al. Update on the diagnosis and management of gestational trophoblastic disease. Int. J. Gynaecol. Obstet.143(Suppl. 2), 79–85 (2018).
- Reynaud D , AbiNahed R, LemaitreNet al. NLRP7 promotes choriocarcinoma growth and progression through the establishment of an immunosuppressive microenvironment. Cancers13(12), 2999 (2021).
- Wang J-M , ZhaoH-X, WangL, GaoZ-Y, YaoY-Q. The human leukocyte antigen G promotes trophoblast fusion and β-hCG production through the Erk1/2 pathway in human choriocarcinoma cell lines. Biochem. Biophys. Res. Comm.434(3), 460–465 (2013).
- Abu-Shawer O , Abu-ShawerM, HirmasNet al. Hematologic markers of distant metastases and poor prognosis in gynecological cancers. BMC Cancer19(1), 141 (2019).
- Proctor MJ , McmillanDC, MorrisonDS, FletcherCD, HorganPG, ClarkeSJ. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br. J. Cancer107(4), 695–699 (2012).
- Du S , FangZ, YeLet al. Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy. Aging (Albany NY)13(13), 17638–17654 (2021).
- Li Y , ZhangZ, HuYet al. Pretreatment neutrophil-to-lymphocyte ratio (NLR) may predict the outcomes of advanced non-small-cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs). Front. Oncol.10, 654 (2020).
- Yang L , ChenH. Establishing the prognostic value of platelet-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis. Int. J. Gynecol. Cancer29(4), 683–690 (2019).
- Rolli M , FransveaE, PilchJ, SavenA, Felding-HabermannB. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc. Natl Acad. Sci. USA100(16), 9482–9487 (2003).
- Quigley DA , KristensenV. Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells. Mol. Oncol.9(10), 2054–2062 (2015).
- Zhang N , JiangJ, TangS, SunG. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Int. Immunopharmacol.85, 106677 (2020).
- Zhou X , LuoG. A meta-analysis of the platelet-lymphocyte ratio: a notable prognostic factor in renal cell carcinoma. Int. J. Biol. Markers37(2), 123–133 (2022).
- Lei X , ChenX, YangY, QinA. Predicting malignant transformation of hydatidiform mole by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio. Chin. J. Reprod. Health33(04), 342–346 (2022).